- €2.69bn
- €5.77bn
- €4.61bn
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | — | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,382 | 2,463 | 3,689 | 4,364 | 4,610 |
Cost of Revenue | |||||
Gross Profit | 2,242 | 2,334 | 3,422 | 3,939 | 4,078 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,970 | 2,263 | 3,387 | 4,029 | 5,480 |
Operating Profit | 412 | 199 | 302 | 335 | -870 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 416 | 175 | 266 | 294 | -918 |
Provision for Income Taxes | |||||
Net Income After Taxes | 341 | 130 | 202 | 215 | -958 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 311 | 164 | -752 | 299 | -817 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 311 | 164 | -751 | 299 | -817 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.38 | 1.05 | 1.05 | 1.27 | 0.228 |
Dividends per Share |